Chemomab Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.

About CMMB

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel. 

CEO
Adi Mor
CEOAdi Mor
Employees
16
Employees16
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2011
Founded2011
Employees
16
Employees16

CMMB Key Statistics

Market cap
10.34M
Market cap10.34M
Price-Earnings ratio
-0.90
Price-Earnings ratio-0.90
Dividend yield
Dividend yield
Average volume
59.64K
Average volume59.64K
High today
$1.80
High today$1.80
Low today
$1.67
Low today$1.67
Open price
$1.72
Open price$1.72
Volume
35.85K
Volume35.85K
52 Week high
$8.76
52 Week high$8.76
52 Week low
$1.54
52 Week low$1.54

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.